One of the things that investors need to be aware of with regard to any kind of success in the stock markets is that they need to be aware of the latest developments in the market. In order to do that, it is necessary for investors to keep an eye on the news from the markets and then identify the companies which could be worth tracking. This article is going to give you a look into some of the companies and stocks which have been in focus in recent days. Here is a quick look at three of those.
Zerify Inc (OTCMKTS:ZRFY) – The first one to make it to the list is the cybersecurity firm Zerify Inc, which is mainly involved in the secure videoconferencing solutions space. That being said, it should also be noted that the company has been in business for more than two decades.
Earlier on in the month on December 19, the company had come into the news cycle after it announced that the company 21st Century Marketing Group had licensed the company’s product Zerify Defender for the purpose of protecting the confidential data of its clients. It was a major new development for the company and it is going to be interesting to see if it leads to any major move in its stock or not.
Pressure Biosciences Inc (OTCMKTS: PBIO) – Last week on December 22 Pressure Biosciences Inc was in the news after the manufacturer of the pressure-based instrument announced its projections for the fourth fiscal quarter. The company announced that the revenues in the fourth quarter would be higher than the revenues in any of the previous four years.
In fact, Pressure Biosciences noted that the revenues could even prove to be the highest in the history of the company. The company also stated that the foundations that have been put in place and the resultant momentum is going to speed up in the future. The commercial release of its Ultra Shear Technology is being seen as a major trigger for the same.
Therma Bright Inc (OTCMKTS: TBRIF) – Last week, Therma Bright Inc was in focus after it came up with an update for the end of the year. The company noted that it continued to get constructive feedback from the regulatory Health Canada with regards to its AcuVid™ COVID-19 Rapid Antigen Saliva Test. It went on to add that it was looking for a regulatory breakthrough in the United States including a breakthrough device designation.